Sezaryen sonrası ağrı tedavisinde epidural %0.2 ropivakain ile %0.2 ropivakain ve 0.75 µg mL-1 sufentanil kombinasyonunun karşılaştırılması

Sezaryen operasyonları sonrası uygulanacak analjezi teknikleri, annelerin bebeklerinin bakımına izin verecek erken mobilizasyon ile birlikte etkin analjezi sağlamalıdır. Bu çalışmada, hasta kontrollü epidural analjezide (HKEA) kullanılan yalnız %0.2 ropivakain ve %0.2 ropivakain+0.75 µg mL-1sufentanilin karşılaştırılması amaçlandı. 50 kadın olgu (ASA I) çalışmaya dahil edildi. Tüm hastalara kombine spinal-epidural anestezi uygulandı. Duyu bloğu 2 dermatom gerileyince analjezik solüsyonların infüzyonuna başlandı. Hastalar randomize olarak 2 gruba ayrıldı (n=25). Grup-I’de %0.2 ropivakain ve 0.75 µg mL-1sufentanil, Grup II’ de yalnız %0.2 ropivakain kullanıldı (yükleme 1.25 mL, kilit süresi 30 dakika, 2.5 mL saat-1 infüzyon ile). Ameliyat sonrası 24 saat süresince ağrı (vizuel analog skala), motor blok (bromaj skalası) ve sedasyon (four-point skala) değerlendirildi. Hemodinamik ve solunumsal parametreler, yan etkiler, total ilaç tüketimi ve ek analjezik gereksinimi kaydedildi. İstatiksel analizde student-t, chi-square ve Mann Whitney U testleri kullanıldı. Demografik veriler, sedasyon skalaları, hemodinamik ve solunumsal parametrelerde gruplar arasında fark saptanmamıştır. Motor blok ve ağrı skorları 2 ve 4. saatte Grup-II’de anlamlı şekilde yüksek bulunmuştur. Total ilaç tüketiminin Grup-I’de 65.24±4.20 mL, Grup II’de 81.1±6.44 mL olduğu gözlenmiştir (P

Comparison of epidural ropivacaine 0.2% and ropivacaine 0.2% in combination with sufentanil 0.75 µg mL-1 for postcaesarean analgesia

Analgesic techniques after c-section must be effective producing early mobilisation to enable mothers to care effort their babies. In this study, the comparison of ropivacaine 0.2% alone, with ropivacaine 0.2%+sufentanil 0.75 µg mL-1 for patient controlled epidural analgesia (PCEA) was aimed. Fifty women (ASA-I) were enrolled in the study. All patients had combined spinal-epidural anaesthesia. Infusion of analgesic solutions was started when sensory level decreased by two dermatome levels. The patients randomly assigned, into two groups (n=25). In Group-I, ropivacaine 0.2% and sufentanil 0.75 µg mL-1, in Group-II, ropivacaine 0.2% alone were applied (bolus 1.25 mL, lockout 30 min, with 2.5 mL h-1 background infusion). Pain, motor blockage and sedation were evaluated during 24 hours after Caesarean, using the scales of visual analogue, bromage, and four-point, respectively. Haemodynamic and respiratory parameters, side effects, total drug consumption and additional analgesic need, were recorded. Statistical analysis included student-t, chi-square, and Mann Whitney U tests. There was no difference in demographic data, sedation scores, haemodynamic and respiratory parameters, between the groups. Motor block and pain scores were significantly higher in Group-II than in Group-I at 2 and 4. h. Total drug consumption was 65.24±4.20 mL for Group-I and 81.1±6.44 mL for Group-II, (P<0.05). Four patients in Group-I and 21 patients in Group-II received additional analgesic. Pruritus was observed more frequently in Group-I. The addition of sufentanil 0.75 µg mL-1 to ropivacaine 0.2% for PCEA after Caesarean led to more effective analgesia and less motor weakness when compared to ropivacaine 0.2% alone, especially during early postoperative period.

___

  • Asik I, Goktug A, Gulay I, Alkis N, Uysalel A: Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour. Eur J Anaesthesiol 2002; 19: 263-270.
  • Bachmann-Mennenga B, Veit G, Biscoping J, Steinicke B, Heesen M: Epidural ropivacaine 1% with and without sufentanil addition for Caesarean section. Acta Anaesthesiol Scand 2005; 49: 525-531.
  • Bachmann-Mennenga B, Veit G, Steinicke B, Biscoping J, Heesen M: Efficacy of sufentanil addition to ropivacaine epidural anaesthesia for Caesarean section. Acta Anaesthesiol Scand 2005; 49: 532–537.
  • Berti M, Casati A, Fanelli G, Albertin A, Palmisano S, Danelli G, Comotti L, Torri G: 0.2% ropivacaine with or without fentanyl for patient-controlled epidural analgesia after major abdominal surgery: a double-blind study. J Clin Anesth 2000; 12: 292–297.
  • Berti M, Danelli G, Antonino FA, Moizo E, Vinciguerra F, Casati A: 0.2% ropivacaine with or without sufentanil for patient-controlled epidural analgesia after anterior cruciate ligament repair. Minerva Anestesiol 2005; 71: 93-100.
  • Boselli E, Debon R, Duflo F, Bryssine B, Allaouchiche B, Chassard D: Ropivacaine 0.15% plus sufentanil 0.5 microg/mL and ropivacaine 0.10% plus sufentanil 0.5 microg/mL are equivalent for patient-controlled epidural analgesia during labor. Anesth Analg 2003; 96: 1173-1177.
  • Brodner G, Mertes N, Van Aken H, Möllhoff T, Zahl M, Wirtz S, Marcus MA, Buerkle H: What concentration of sufentanil should be combined with ropivacaine 0.2% wt/vol for postoperative patient-controlled epidural analgesia? Anesth Analg 2000; 90: 649–657.
  • Brown DL, Gottumkkala V. In: Chestnut DH, editor. Obstetric Anesthesia. Philadelphia: Elsevier Mosby, 2004. pp. 171-190.
  • Buggy DJ, Allsager CM, Coley S: Profound motor blockade with epidural ropivacaine following spinal bupivacaine. Anaesthesia 1999; 54: 895–898.
  • Buggy DJ, Hall NA, Shah J, Brown J, Williams J: Motor block during patient-controlled epidural analgesia with ropivacaine or ropivacaine/fentanyl after intrathecal bupivacaine for Caesarean section. Br J Anaesth 2000; 85: 468–470.
  • Chestnut DH, Owen CL, Bates JN: Continuous infusion epidural analgesia during labor. Anesthesiology 1988; 68: 754–759.
  • De Cosmo G, Primieri P, Adducci E, Fiorenti M, Beccia G: Epidural analgesia in abdominal surgery: 0.2% ropivacaine with sufentanil. Minerva Anestesiol 2004; 70: 503–508.
  • Debon R, Allaouchiche B, Duflo F, Boselli E, Chassard D: The analgesic effect of sufentanil combined with ropivacaine 0.2% for labor analgesia: a comparison of three sufentanil doses. Anesth Analg 2001; 92: 180-183.
  • Desborough JP: Physiological responses to surgery and trauma. In: Desborough JP, editor. Foundation of Anaesthesia. London: 1999. pp. 713–720.
  • Erdine S: Tarihçe. In: Erdine S, editor. Ağrı. Istanbul: Nobel Tıp Kitabevleri, 2000. pp. 3-29.
  • Fischer C, Blanie P, Jaouen E, Vayssiere C, Kaloul I, Coltat JC. Ropivacaine 0.1%, plus sufentanil 0.5 microg/ml versus bupivacaine 0.1%, plus sufentanil 0.5 microg/ml using patient-controlled epidural analgesia for labor: a dou ble-blind comparison. Anesthesiology 2000; 92: 1588-1593.
  • Gogarten W, Van de Velde M, Soetens F, Van Aken H, Brodner G, Gramke HF, Soetens M, Marcus MA. A multicentre trial comparing different concentrations of ropivacaine plus sufentanil with bupivacaine plus sufentanil for patient-controlled epidural analgesia in labour. Eur J Anaesthesiol 2004; 21: 38-45.
  • Hodgson PS, Liu SS. A comparison of ropivacaine with fentanyl to bupivacaine with fentanyl for postoperative patient-controlled epidural analgesia. Anesth Analg 2001; 92: 1024-1028.
  • Hug CC: Pain management. In: Morgan GE, Mikhail MS, Murray MJ editors. Clinical Anesthesiology. New York: McGrawHill Companies, 2002. pp. 309-358.
  • Kampe S, Kiencke P, Delis A, Auweiler M, Konig DP, Kasper SM: The continuous epidural infusion of ropivacaine 0.1% with 0.5 microg x mL(-1) sufentanil provides effective postoperative analgesia after total hip replacement: a pilot study. Can J Anaesth 2003; 50: 580-585.
  • Kayaalp SO: Opioids. In: Kayaalp SO, editor. Medical Pharmacology. Ankara: Feryal Matbaacılık, 2002. pp. 824–845.
  • Lorenzini C, Moreira LB, Ferreira MB: Efficacy of ropivacaine compared with ropivacaine plus sufentanil for postoperative analgesia after major knee surgery. Anaesthesia 2002; 57: 424–428.
  • Michael AA, Brian R: Postoperative pain. In: Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Bonica’s Management of Pain. Philadelphia: Lippincott Williams and Wilkins, 2001. pp. 765-776.
  • Onal A. Algology. In: Onal A, editor. Pain. ‹stanbul: Nobel Medical Publishers, 2004. pp. 1-21.
  • Ozyalçın S: Akut ağrıda stress yanıt. In: Ozyalçın S, editor. Akut ağrı. Güneş Kitabevi, 2005. pp. 25-36.
  • Pirbudak L, Tuncer S, Kocoglu H, Goksu S, Celik C. Fentanyl added to bupivacaine 0.05% or ropivacaine 0.05% in patient-controlled epidural analgesia in labour. Eur J Anaesthesiol 2002; 19: 271–275.
  • Santos AC, Braveman FR, Finster M: Obstetric anesthesia. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical Anesthesia. Philadelphia: Lippincott Williams and Wilkins, 2006. pp.1152–1180.
  • Scott DA, Blake D, Buckland M, Etches R, Halliwell R, Marsland C, Merridew G, Murphy D, Paech M, Schug SA, Turner G, Walker S, Huizar K, Gustafsson U: A comparison of epidural ropivacaine infusion alone and in combination with 1, 2 and 4 mcgr/ml fentanyl for seventy-two hours of postoperative analgesia after major abdominal sur gery. Anesth Analg 1999; 88: 857-864.
  • Tuncel G, Ozalp G, Savli S, Canoler O, Kaya M, Kadiogullari N: Epidural ropivacaine or sufentanil-ropivacaine infusions for post-thoracotomy pain. Eur J Cardiothorac Surg 2005; 28: 375–379.
  • Turk DC, Akiko O: Pain terms and taxonomies of pain. In: Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Bonica’s Management of Pain. Philadelphia: Lippincott Williams and Wilkins, 2001. pp. 17-25.